Compare RTX & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RTX | ABT |
|---|---|---|
| Founded | 1934 | 1888 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 234.3B | 222.8B |
| IPO Year | N/A | N/A |
| Metric | RTX | ABT |
|---|---|---|
| Price | $170.71 | $124.99 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 18 |
| Target Price | ★ $175.00 | $146.61 |
| AVG Volume (30 Days) | 4.2M | ★ 6.5M |
| Earning Date | 10-21-2025 | 01-21-2026 |
| Dividend Yield | 1.59% | ★ 1.89% |
| EPS Growth | 38.64 | ★ 141.97 |
| EPS | 4.87 | ★ 7.96 |
| Revenue | ★ $85,988,000,000.00 | $43,843,000,000.00 |
| Revenue This Year | $8.82 | $7.56 |
| Revenue Next Year | $6.17 | $7.96 |
| P/E Ratio | $35.14 | ★ $15.71 |
| Revenue Growth | ★ 8.79 | 6.37 |
| 52 Week Low | $112.27 | $110.86 |
| 52 Week High | $181.31 | $141.23 |
| Indicator | RTX | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 47.30 | 41.37 |
| Support Level | $166.74 | $124.06 |
| Resistance Level | $172.09 | $129.85 |
| Average True Range (ATR) | 3.23 | 2.81 |
| MACD | -0.71 | -0.21 |
| Stochastic Oscillator | 35.57 | 27.79 |
RTX is an aerospace and defense manufacturer formed from the merger of United Technologies and Raytheon, with roughly equal exposure across three segments, mostly as a supplier to commercial aerospace and to the defense market: Collins Aerospace, a diversified aerospace supplier; Pratt & Whitney, a commercial and military aircraft engine manufacturer; and Raytheon, a defense prime contractor providing a mix of missiles, missile defense systems, sensors, hardware, and communications technology to the military.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.